Compare $AIM vs $VSBC | Chartloom

Compare

$AIM vs $VSBC

AIM ImmunoTech Inc · Vitaspring Biomedical Co. Ltd

AIM

AIM ImmunoTech Inc

VSBC

Vitaspring Biomedical Co. Ltd

Compare $AIM vs $VSBC

Comparing AIM ImmunoTech Inc and Vitaspring Biomedical Co. Ltd

AIMAIM ImmunoTech Inc

VSBCVitaspring Biomedical Co. Ltd

AIMAIM ImmunoTech Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.5%

YTD performance

-84.4%

52W performance

-92.8%

FCF yield

-292.9%

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AIM

VSBC

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

AIM$5M

VSBC$7M

Enterprise Value

AIM$-1M

VSBC$9M

Price

AIM$0.18

VSBC$0.00

P/E Ratio

AIMN/A

VSBCN/A

P/S Ratio

AIM52.52x

VSBC0.99x

EV/Sales

AIM-13.57x

VSBC0.99x

EV/EBITDA

AIM0.00x

VSBC4.29x

P/B Ratio

AIM0.91x

VSBC3.92x

P/FCF Ratio

AIMN/A

VSBC765.53x

EV/FCF

AIM0.09x

VSBC1,044.32x

PEG Ratio

AIMN/A

VSBCN/A

Forward P/E (NTM)

AIMN/A

VSBCN/A

Forward P/S (NTM)

AIMN/A

VSBCN/A

Revenue (TTM)

AIM$95K

VSBC$0

Revenue Growth (YoY)

AIM-21.5%

VSBCN/A

Forward Rev Growth

AIM-32.4%

VSBC0.0%

Gross Margin (TTM)

AIM-23.2%

VSBC39.3%

Operating Margin (TTM)

AIM0.0%

VSBC23.4%

EBITDA Margin (TTM)

AIM-10985.3%

VSBC0.0%

Net Margin (TTM)

AIM-15021.1%

VSBC18.2%

FCF Margin (TTM)

AIM-15385.3%

VSBCN/A

Net Income (TTM)

AIM$-14M

VSBC$-456K

FCF (TTM)

AIM$-15M

VSBC$9K

EPS (TTM)

AIM-$0.83

VSBC-$0.00

ROE (TTM)

AIM-13803.0%

VSBC70.0%

ROA (TTM)

AIM-17514.0%

VSBC-211240.0%

ROIC (TTM)

AIM-7694.0%

VSBC70.0%

Cash

AIM$10M

VSBC$13K

Debt

AIM$4M

VSBC$2M

Net Cash/Debt

AIM$6M

VSBC$-2M

Current Ratio (TTM)

AIM2.11x

VSBC0.00x

Quick Ratio (TTM)

AIM2.01x

VSBC0.00x

Debt/Equity (TTM)

AIM0.47x

VSBC0.00x

Debt/Assets (TTM)

AIM0.0%

VSBC0.0%

Interest Coverage (TTM)

AIMN/A

VSBCN/A

Net Debt/EBITDA (TTM)

AIM0.00x

VSBC0.00x

Beta

AIM1.35

VSBC-1.47

52W Performance

AIM-92.8%

VSBC-100.0%

YTD Performance

AIM-84.4%

VSBC-100.0%

% from 52W High

AIM-93.6%

VSBC-100.0%

% from 52W Low

AIM8.4%

VSBCN/A

Asset Turnover (TTM)

AIM0.01x

VSBC2.66x

FCF Yield (TTM)

AIM-292.9%

VSBC0.1%

Earnings Yield (TTM)

AIM-286.0%

VSBC-6.9%

Dividend Yield (TTM)

AIMN/A

VSBCN/A

Rule of 40

AIM-15,406.8

VSBC0.0

EV/GP/RG

AIMN/A

VSBCN/A

Ticker research

View AIM research View VSBC research

Metric	AIM AIM ImmunoTech Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$9M
Price	$0.18	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	0.99x
EV/Sales	-13.57x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.91x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	0.09x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$0
Revenue Growth (YoY)	-21.5%	N/A
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	-10985.3%	0.0%
Net Margin (TTM)	-15021.1%	18.2%
FCF Margin (TTM)	-15385.3%	N/A
Net Income (TTM)	$-14M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$0.83	-$0.00
ROE (TTM)	-13803.0%	70.0%
ROA (TTM)	-17514.0%	-211240.0%
ROIC (TTM)	-7694.0%	70.0%
Financial Health
Cash	$10M	$13K
Debt	$4M	$2M
Net Cash/Debt	$6M	$-2M
Current Ratio (TTM)	2.11x	0.00x
Quick Ratio (TTM)	2.01x	0.00x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	-1.47
52W Performance	-92.8%	-100.0%
YTD Performance	-84.4%	-100.0%
% from 52W High	-93.6%	-100.0%
% from 52W Low	8.4%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.66x
FCF Yield (TTM)	-292.9%	0.1%
Earnings Yield (TTM)	-286.0%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View VSBC research

Valuation

P/S Ratio

VSBC

0.99x

AIM

52.52x

EV/FCF

AIM

0.09x

VSBC

1,044.32x

Growth & revenue

Revenue Growth TTM

AIM

-21.5%

Forward Revenue Growth

VSBC

0.0%

AIM

-32.4%

Profitability & performance

Gross Margin

VSBC

39.3%

AIM

-23.2%

ROE

VSBC

70.0%

AIM

-13803.0%

FCF Yield %

VSBC

0.1%

AIM

-292.9%

52-Week Performance

AIM

-92.8%

VSBC

-100.0%

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

AIM$5M

VSBC$7M

Enterprise Value

AIM$-1M

VSBC$9M

Price

AIM$0.18

VSBC$0.00

P/E Ratio

AIMN/A

VSBCN/A

P/S Ratio

AIM52.52x

VSBC0.99x

EV/Sales

AIM-13.57x

VSBC0.99x

EV/EBITDA

AIM0.00x

VSBC4.29x

P/B Ratio

AIM0.91x

VSBC3.92x

P/FCF Ratio

AIMN/A

VSBC765.53x

EV/FCF

AIM0.09x

VSBC1,044.32x

PEG Ratio

AIMN/A

VSBCN/A

Forward P/E (NTM)

AIMN/A

VSBCN/A

Forward P/S (NTM)

AIMN/A

VSBCN/A

Revenue (TTM)

AIM$95K

VSBC$0

Revenue Growth (YoY)

AIM-21.5%

VSBCN/A

Forward Rev Growth

AIM-32.4%

VSBC0.0%

Gross Margin (TTM)

AIM-23.2%

VSBC39.3%

Operating Margin (TTM)

AIM0.0%

VSBC23.4%

EBITDA Margin (TTM)

AIM-10985.3%

VSBC0.0%

Net Margin (TTM)

AIM-15021.1%

VSBC18.2%

FCF Margin (TTM)

AIM-15385.3%

VSBCN/A

Net Income (TTM)

AIM$-14M

VSBC$-456K

FCF (TTM)

AIM$-15M

VSBC$9K

EPS (TTM)

AIM-$0.83

VSBC-$0.00

ROE (TTM)

AIM-13803.0%

VSBC70.0%

ROA (TTM)

AIM-17514.0%

VSBC-211240.0%

ROIC (TTM)

AIM-7694.0%

VSBC70.0%

Cash

AIM$10M

VSBC$13K

Debt

AIM$4M

VSBC$2M

Net Cash/Debt

AIM$6M

VSBC$-2M

Current Ratio (TTM)

AIM2.11x

VSBC0.00x

Quick Ratio (TTM)

AIM2.01x

VSBC0.00x

Debt/Equity (TTM)

AIM0.47x

VSBC0.00x

Debt/Assets (TTM)

AIM0.0%

VSBC0.0%

Interest Coverage (TTM)

AIMN/A

VSBCN/A

Net Debt/EBITDA (TTM)

AIM0.00x

VSBC0.00x

Beta

AIM1.35

VSBC-1.47

52W Performance

AIM-92.8%

VSBC-100.0%

YTD Performance

AIM-84.4%

VSBC-100.0%

% from 52W High

AIM-93.6%

VSBC-100.0%

% from 52W Low

AIM8.4%

VSBCN/A

Asset Turnover (TTM)

AIM0.01x

VSBC2.66x

FCF Yield (TTM)

AIM-292.9%

VSBC0.1%

Earnings Yield (TTM)

AIM-286.0%

VSBC-6.9%

Dividend Yield (TTM)

AIMN/A

VSBCN/A

Rule of 40

AIM-15,406.8

VSBC0.0

EV/GP/RG

AIMN/A

VSBCN/A

Ticker research

View AIM research View VSBC research

Metric	AIM AIM ImmunoTech Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$9M
Price	$0.18	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	0.99x
EV/Sales	-13.57x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.91x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	0.09x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$0
Revenue Growth (YoY)	-21.5%	N/A
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	-10985.3%	0.0%
Net Margin (TTM)	-15021.1%	18.2%
FCF Margin (TTM)	-15385.3%	N/A
Net Income (TTM)	$-14M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$0.83	-$0.00
ROE (TTM)	-13803.0%	70.0%
ROA (TTM)	-17514.0%	-211240.0%
ROIC (TTM)	-7694.0%	70.0%
Financial Health
Cash	$10M	$13K
Debt	$4M	$2M
Net Cash/Debt	$6M	$-2M
Current Ratio (TTM)	2.11x	0.00x
Quick Ratio (TTM)	2.01x	0.00x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	-1.47
52W Performance	-92.8%	-100.0%
YTD Performance	-84.4%	-100.0%
% from 52W High	-93.6%	-100.0%
% from 52W Low	8.4%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.66x
FCF Yield (TTM)	-292.9%	0.1%
Earnings Yield (TTM)	-286.0%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View VSBC research